Prognosis of rare pathological primary urethral carcinoma

9Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Purpose: Urethral carcinoma (UC), as a rare tumor, is not widely studied. There have been no systematic studies of rare pathological types of UC. We conducted this study to further investigate rare pathological types of primary urethral carcinoma (PUC). Materials and methods: We used the population-based Surveillance, Epidemiology, and End Results (SEER) database to evaluate prognostic factors in rare pathological types of PUC. From 1978 to 2015, 2,651 and 257 cases were identified in the SEER database as common and rare pathological types of PUC, respectively. Overall and cancer-specific survival (CSS) times were computed using the Kaplan–Meier method, and the Cox proportional hazards analysis was used to evaluate patient age at diagnosis, gender, race, and TNM stage. Results: The median overall survival (OS) rates were 36 and 59 months for rare and common pathological groups, respectively, and their respective 10-year OS rates were 31.9% and 42.4%, respectively. The median CSS rate was 61 months for the rare pathological group. Through multivariate analysis, it was found that age, race, T stage, and M stage were independent prognostic risk factors for rare pathological type of urethral cancer. In the age group, the HR ratio of patients aged older than 60 years and younger or equal to 60 years was 2.778 (P<0.001). The HR ratio of other races to Whites was 1.444 (P=0.040). In TNM staging, the HR ratio between T3–T4 and Ta–T2 was 2.386 (P=0.046), and the HR value of M1 and M0 was 5.847 (P<0.001). Conclusion: Age, race, T stage, and M stage were predictive of OS and CSS in rare pathological PUC.

Author supplied keywords

References Powered by Scopus

Cancer statistics, 2016

23614Citations
N/AReaders
Get full text

Rare cancers are not so rare: The rare cancer burden in Europe

608Citations
N/AReaders
Get full text

Incidence of primary urethral carcinoma in the United States

173Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Abudurexiti, M., Wang, J., Shao, N., Wan, F. N., Zhu, Y., Dai, B., & Ye, D. W. (2018). Prognosis of rare pathological primary urethral carcinoma. Cancer Management and Research, 10, 6815–6822. https://doi.org/10.2147/CMAR.S184197

Readers' Seniority

Tooltip

Researcher 2

67%

Professor / Associate Prof. 1

33%

Readers' Discipline

Tooltip

Medicine and Dentistry 2

100%

Save time finding and organizing research with Mendeley

Sign up for free